GlassScriptPhysician profile
Jaclyn Bondhus
NPI 1548763048
$6,102.93
in general payments reported to CMS, 2019-2025
24 companies · $2,222 in 2025
The $2,222 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $281 · 2022: $297 · 2023: $1,722 · 2024: $1,582 · 2025: $2,222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,249 · Education: $276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,248.81 |
| Education | $276.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,255.30 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $597.08 | 2023-2025 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $555.18 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $488.43 | 2022-2025 | Ilumya, Winlevi |
| Genzyme Corporation | $423.45 | 2022-2025 | |
| Janssen Biotech, INC. | $420.90 | 2021-2025 | Tremfya, Stelara, Simponi Aria |
| Ucb, INC. | $406.65 | 2023-2025 | Bimzelx, Cimzia |
| Lilly USA, LLC | $283.45 | 2022-2025 | Taltz, Ebglyss, Olumiant |
| Regeneron Healthcare Solutions, INC. | $282.52 | 2023-2025 | Dupixent |
| Pfizer INC. | $267.16 | 2023-2025 | |
| Galderma Laboratories, L.P. | $235.92 | 2025 | Nemluvio |
| Arcutis Biotherapeutics, INC. | $203.77 | 2023-2024 | Zoryve |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $198.67 | 2023-2025 | Jublia, Cabtreo, Arazlo |
| Janssen Scientific Affairs, LLC | $125.00 | 2021 | |
| Organon LLC | $107.46 | 2025 | Vtama, Hadlima |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $44.14 | 2023-2024 | Vtama |
| Almirall LLC | $38.83 | 2025 | Cordran, Klisyri |
| Leo Pharma INC. | $29.94 | 2025 | Anzupgo |
| Kyowa Kirin, INC. | $28.06 | 2025 | |
| Incyte Corporation | $25.94 | 2022-2023 | Opzelura |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.44 | 2022 | |
| Lnhc, INC | $25.39 | 2025 | Zelsuvmi |
| Journey Medical Corporation | $17.78 | 2022 | |
| Organogenesis INC. | $16.47 | 2023 | Puraply |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaclyn Bondhus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.